• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏生物工程移植。

Kidney Bioengineering for Transplantation.

机构信息

Department of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.

出版信息

Transplantation. 2023 Sep 1;107(9):1883-1894. doi: 10.1097/TP.0000000000004526. Epub 2023 Aug 21.

DOI:10.1097/TP.0000000000004526
PMID:36717963
Abstract

The kidney is an important organ for maintenance of homeostasis in the human body. As renal failure progresses, renal replacement therapy becomes necessary. However, there is a chronic shortage of kidney donors, creating a major problem for transplantation. To solve this problem, many strategies for the generation of transplantable kidneys are under investigation. Since the first reports describing that nephron progenitors could be induced from human induced pluripotent stem cells, kidney organoids have been attracting attention as tools for studying human kidney development and diseases. Because the kidney is formed through the interactions of multiple renal progenitors, current studies are investigating ways to combine these progenitors derived from human induced pluripotent stem cells for the generation of transplantable kidney organoids. Other bioengineering strategies, such as decellularization and recellularization of scaffolds, 3-dimensional bioprinting, interspecies blastocyst complementation and progenitor replacement, and xenotransplantation, also have the potential to generate whole kidneys, although each of these strategies has its own challenges. Combinations of these approaches will lead to the generation of bioengineered kidneys that are transplantable into humans.

摘要

肾脏是人体维持内环境稳定的重要器官。随着肾衰竭的进展,肾脏替代治疗变得必要。然而,肾脏供体长期短缺,这给移植带来了重大问题。为了解决这个问题,许多生成可移植肾脏的策略正在研究中。自从首次报道描述肾祖细胞可以从人诱导多能干细胞中诱导产生以来,肾类器官已作为研究人类肾脏发育和疾病的工具而受到关注。由于肾脏是通过多种肾祖细胞的相互作用形成的,目前的研究正在探索将这些源自人诱导多能干细胞的祖细胞组合起来生成可移植的肾类器官的方法。其他生物工程策略,如支架的脱细胞和再细胞化、3 维生物打印、种间胚泡互补和祖细胞替换以及异种移植,也有可能生成整个肾脏,尽管这些策略各有挑战。这些方法的组合将导致生成可移植到人体的生物工程肾脏。

相似文献

1
Kidney Bioengineering for Transplantation.肾脏生物工程移植。
Transplantation. 2023 Sep 1;107(9):1883-1894. doi: 10.1097/TP.0000000000004526. Epub 2023 Aug 21.
2
Bioengineering strategies for nephrologists: kidney was not built in a day.生物工程策略助力肾病学家:肾脏不是一日建成的。
Expert Opin Biol Ther. 2020 May;20(5):467-480. doi: 10.1080/14712598.2020.1709439. Epub 2020 Jan 23.
3
Vascular bioengineering of scaffolds derived from human discarded transplant kidneys using human pluripotent stem cell-derived endothelium.利用人多能干细胞衍生的内皮细胞对来源于人废弃移植肾脏的支架进行血管生物工程改造。
Am J Transplant. 2019 May;19(5):1328-1343. doi: 10.1111/ajt.15200. Epub 2019 Jan 10.
4
From organoids to transplantable artificial kidneys.从类器官到可移植的人工肾脏。
Transpl Int. 2019 Jun;32(6):563-570. doi: 10.1111/tri.13404. Epub 2019 Mar 4.
5
Whole kidney engineering for clinical translation.用于临床转化的全肾工程。
Curr Opin Organ Transplant. 2015 Apr;20(2):165-70. doi: 10.1097/MOT.0000000000000173.
6
Evaluation of the ability of human induced nephron progenitor cells to form chimeric renal organoids using mouse embryonic renal progenitor cells.利用小鼠胚胎肾祖细胞评估人诱导肾祖细胞形成嵌合肾类器官的能力。
Biochem Biophys Res Commun. 2023 Jun 25;662:18-25. doi: 10.1016/j.bbrc.2023.04.052. Epub 2023 Apr 18.
7
Recent advances in renal regeneration.肾脏再生的最新进展。
F1000Res. 2019 Feb 25;8. doi: 10.12688/f1000research.17127.1. eCollection 2019.
8
Generation of chimeric kidneys using progenitor cell replacement: Oshima Award Address 2021.使用祖细胞替代法生成嵌合肾脏:大岛奖 2021 年度演讲。
Clin Exp Nephrol. 2022 Jun;26(6):491-500. doi: 10.1007/s10157-022-02191-3. Epub 2022 Feb 9.
9
Can stem cells be used to generate new lungs? Ex vivo lung bioengineering with decellularized whole lung scaffolds.干细胞能否用于生成新的肺脏?使用去细胞化全肺支架的体外肺生物工程。
Respirology. 2013 Aug;18(6):895-911. doi: 10.1111/resp.12102.
10
Generation of kidney from pluripotent stem cells via blastocyst complementation.多能干细胞通过胚泡互补生成肾脏。
Am J Pathol. 2012 Jun;180(6):2417-26. doi: 10.1016/j.ajpath.2012.03.007. Epub 2012 Apr 14.

引用本文的文献

1
Preclinical approaches in regenerative medicine for treating end-stage renal disease: a scoping review.再生医学治疗终末期肾病的临床前研究方法:一项范围综述
Front Endocrinol (Lausanne). 2025 Jul 18;16:1549744. doi: 10.3389/fendo.2025.1549744. eCollection 2025.
2
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery.细胞与组织重编程:开启药物研发的新时代。
Pharmacol Rev. 2025 Jun 26;77(5):100077. doi: 10.1016/j.pharmr.2025.100077.
3
Kidney and Bladder Transplantation: Advances, Barriers, and Emerging Solutions.
肾脏与膀胱移植:进展、障碍及新出现的解决方案
Medicina (Kaunas). 2025 Jun 5;61(6):1045. doi: 10.3390/medicina61061045.
4
Preparation and characterization of a rat uterine decellularized scaffold.大鼠子宫脱细胞支架的制备与表征
Gland Surg. 2024 Dec 31;13(12):2372-2382. doi: 10.21037/gs-24-474. Epub 2024 Dec 19.
5
Influence of gut flora on diabetes management after kidney transplantation.肠道菌群对肾移植术后糖尿病管理的影响。
BMC Nephrol. 2024 Dec 23;25(1):468. doi: 10.1186/s12882-024-03899-y.
6
Exploring immune response toward transplanted human kidney tissues assembled from organoid building blocks.探索对由类器官构建模块组装而成的移植人类肾脏组织的免疫反应。
iScience. 2024 Sep 13;27(10):110957. doi: 10.1016/j.isci.2024.110957. eCollection 2024 Oct 18.
7
Delivery of exogenous miR-19b by Wharton's Jelly Mesenchymal Stem Cells attenuates transplanted kidney ischemia/reperfusion injury by regulating cellular metabolism.脐带来源的间充质干细胞递送外源性miR-19b通过调节细胞代谢减轻移植肾缺血/再灌注损伤。
Drug Deliv Transl Res. 2025 Mar;15(3):925-938. doi: 10.1007/s13346-024-01645-3. Epub 2024 Jun 25.
8
Artificial kidney: Challenges and opportunities.人工肾脏:挑战与机遇。
World J Transplant. 2024 Mar 18;14(1):89025. doi: 10.5500/wjt.v14.i1.89025.